Joinn Laboratories (China) Co. Ltd. provided earnings guidance for the period from January 1, 2021 to June 30, 2021. For the period, it is expected that the net profit attributable to the shareholders of the Company for the period from January to June 2021 will be approximately RMB 149.2238 million to RMB 158.2461 million, representing an increase of approximately RMB 73.559 million to RMB 82.5813 million as compared with the data in the financial statements for the corresponding period of last year, representing a period-on-period increase of approximately 97.2% to 109.1%. It is expected that the net profit attributable to the shareholders of the Company for the period from January to June 2021 will increase by approximately RMB 59.0003 million to RMB 68.0226 million as compared with the data in the restated financial statements for the corresponding period of last year, representing a period-on-period increase of approximately 65.4% to 75.4%. It is expected that the revenue from January to June 2021 will increase by approximately RMB 117.3337 million to RMB 157.0692 million as compared with the data in the financial statements for the corresponding period of last year, representing a period-on-period increase of approximately 29.5% to 39.5%.